한글목차

세계의 조직공학 시장 규모는 2024년에 135억 달러에 달하며, 2030년까지 CAGR은 9.20%로 큰 성장이 예측됩니다.

조직공학은 재생의료와 생명공학 분야에서 가장 역동적이고 빠르게 진화하고 있는 분야입니다. 이 분야는 생물학, 화학, 공학의 원리를 적용하여 의료용으로 기능적인 조직과 장기를 만들어내는 분야입니다. 시장 성장은 장기 이식에 대한 수요 증가, 기증 장기의 부족, 첨단 치료 솔루션의 필요성에 의해 주도되고 있습니다.

조직공학 시장 확대의 주요 요인은 심혈관 질환, 당뇨병, 정형외과 질환과 같은 만성질환 및 상해의 유병률 증가입니다. 조직공학은 이러한 중요한 건강 문제를 해결하기 위해 인공장기, 조직, 임플란트 등 환자 맞춤형 치료 개발을 위한 혁신적인 솔루션을 제공합니다. 또한 세계 인구의 고령화로 인해 노인들이 삶의 질을 향상시키기 위해 조직 기반 치료를 더 자주 필요로 하므로 시장 성장에 더욱 기여하고 있습니다.

생명공학, 바이오소재, 3D 프린팅의 기술 발전은 조직공학을 새로운 차원으로 끌어올리고 있습니다. 기업과 연구자들은 자연 장기를 충실하게 모방한 복잡하고 기능적인 조직을 만들어 이식 성공률을 높이고 거부반응의 위험을 줄이기 위해 이러한 기술 혁신을 점점 더 많이 활용하고 있습니다. 줄기세포 연구, CRISPR-Cas9와 같은 유전자 편집 기술, 생체 적합성 재료의 통합은 조직 공학의 맞춤형 의료 접근 방식을 위한 길을 열었습니다.

세계 조직공학 시장은 피부 이식, 뼈와 연골 복원, 심장 판막, 심지어 신장이나 간과 같은 장기 전체에 이르기까지 다양한 용도로 활용되고 있습니다. 이러한 용도는 정형외과에서 피부과, 순환기내과에 이르기까지 다양한 의료 분야에 걸쳐 있으며, 이는 시장의 다용도성과 성장 잠재력을 강조하고 있습니다.

주요 시장 성장 촉진요인

만성질환 및 부상 유병률 증가

주요 시장이 해결해야 할 과제

복잡한 규제 프레임워크

주요 시장 동향

다양한 용도

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 세계의 조직공학 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 재료 유형별(합성 재료, 생물 유래 재료, 기타)
  • 용도별(정형외과, 근골격·척추, 신경학, 심장학, 피부·외피, 기타)
  • 최종사용자별(병원, 암연구 센터, 학술 조사기관, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵
  • 재료 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제5장 아시아태평양의 조직공학 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 재료 유형별
  • 용도별
  • 최종사용자별
  • 국가별
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽의 조직공학 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 조직공학 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 멕시코
  • 캐나다

제8장 남미의 조직공학 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카의 조직공학 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트

제10장 시장 역학

• 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제12장 세계의 조직공학 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Zimmer Biomet Holdings Inc.
• Stryker Corporation Holdings
• 3D BioFibR Inc.
• Integra LifeSciences Corporation
• CollPlant Biotechnologies Ltd.
• AbbVie(Allergan Aesthetics)
• Becton, Dickinson and Company
• Athersys, Inc.
• BioTissue
• Japan Tissue Engineering Co., Ltd

제15장 전략적 제안

제16장 조사회사 소개·면책사항

영문목차

The Global Tissue Engineering Market was valued at USD 13.50 billion in 2024 and is projected to experience significant growth, with a compound annual growth rate (CAGR) of 9.20% through 2030. Tissue engineering has become a dynamic and rapidly evolving segment within regenerative medicine and biotechnology. This field involves applying principles from biology, chemistry, and engineering to create functional tissues and organs for medical applications. The market's growth is driven by the increasing demand for organ transplants, a shortage of donor organs, and the need for advanced therapeutic solutions.

A key driver behind the expansion of the tissue engineering market is the rising incidence of chronic diseases and injuries, such as cardiovascular diseases, diabetes, and orthopedic conditions. Tissue engineering offers innovative solutions for the development of patient-specific treatments, including engineered organs, tissues, and implants, addressing these critical health issues. Additionally, the aging global population further contributes to the market's growth, as elderly individuals frequently require tissue-based therapies to enhance their quality of life.

Technological advancements in biotechnology, biomaterials, and 3D printing are propelling tissue engineering to new levels. Companies and researchers are increasingly leveraging these innovations to create complex, functional tissues that closely mimic natural organs, improving transplant success rates and reducing rejection risks. The integration of stem cell research, gene editing techniques such as CRISPR-Cas9, and biocompatible materials has paved the way for personalized medicine approaches within tissue engineering.

The global tissue engineering market is characterized by a broad range of applications, including skin grafts, bone and cartilage repair, heart valves, and even whole organs such as kidneys and livers. These applications span various medical fields, from orthopedics to dermatology and cardiology, highlighting the market's versatility and growth potential.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Injuries

The tissue engineering market is experiencing rapid growth, largely driven by the increasing global prevalence of chronic diseases and injuries. Cardiovascular diseases, which impact the heart and blood vessels, account for 18 million deaths annually worldwide, with cancer causing 9 million deaths and chronic respiratory diseases contributing to 4 million fatalities. Diabetes is responsible for 2 million deaths each year. These figures emphasize the substantial health burden posed by non-communicable diseases, underscoring the critical need for innovative healthcare solutions. As the demand for regenerative treatments grows, tissue engineering is emerging as a crucial component of modern medicine.

Chronic conditions such as cardiovascular diseases, diabetes, orthopedic disorders, and trauma-related injuries necessitate advanced tissue regeneration and organ repair solutions. Tissue engineering offers effective regenerative solutions to repair or replace damaged tissues resulting from these conditions. For example, tissue-engineered blood vessels, heart valves, and cardiac patches are in high demand due to the increasing incidence of cardiovascular complications. Similarly, tissue-engineered skin grafts and cell-based therapies are helping diabetic patients heal chronic wounds and foot ulcers.

As healthcare systems shift focus toward treating chronic illnesses, bioprinted tissues, scaffold-based regenerative treatments, and stem cell therapies are becoming key solutions, further driving the market's expansion.

Key Market Challenges

Complex Regulatory Frameworks

The complex regulatory landscape is a significant challenge to the growth and development of the Global Tissue Engineering Market. While regulations are necessary to ensure the safety and efficacy of medical products, the evolving nature of tissue engineering presents unique obstacles for both industry stakeholders and regulatory bodies. A major challenge is the classification and oversight of tissue-engineered products, which may fall under various regulatory categories, including medical devices, biologics, or combination products, depending on their intended use and composition. This ambiguity often requires engagement with multiple regulatory agencies, each with its own set of requirements, making the process time-consuming and cumbersome.

The lengthy and stringent approval processes for tissue-engineered products are another major hurdle. Regulatory agencies, such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe, require extensive preclinical and clinical data to demonstrate the safety and efficacy of these products. While this is crucial for patient safety, it can lead to delays in market entry and increased development costs. Additionally, the rapid pace of advancements in tissue engineering often outstrips the ability of regulators to adapt their frameworks, creating uncertainty for companies engaged in R&D.

Key Market Trends

Diverse Range of Applications

The Global Tissue Engineering Market is experiencing significant growth, primarily due to its broad range of applications across various medical fields. Initially focused on repairing and replacing damaged tissues, tissue engineering has expanded to address a wide array of healthcare challenges, driving market growth.

One notable application is in orthopedics and musculoskeletal medicine. Tissue-engineered solutions are helping patients with bone fractures, cartilage defects, and joint injuries regenerate these essential structures. Advanced biomaterials and scaffold designs are enabling the creation of custom-made bone grafts and cartilage implants that integrate seamlessly with patients' tissues, improving mobility and reducing pain.

In dermatology, tissue-engineered skin substitutes are offering effective solutions for chronic wounds, burns, and skin defects. These skin grafts promote tissue regeneration, enhance healing, and reduce scarring. In cardiology, tissue-engineered heart valves and cardiac patches hold significant potential, offering alternatives to traditional treatments and improving cardiac function.

Beyond these areas, tissue engineering is also making strides in ophthalmology, neurology, and urology. For instance, tissue-engineered corneas are being developed to treat vision impairments, while neural tissue engineering is targeting spinal cord injuries and neurodegenerative disorders. Additionally, tissue-engineered bladders and urethras are being explored to address urinary tract conditions.

Key Market Players

• Zimmer Biomet Holdings Inc.
• Stryker Corporation
• 3D BioFibR Inc.
• Integra LifeSciences Corporation
• CollPlant Biotechnologies Ltd.
• AbbVie (Allergan Aesthetics)
• Becton, Dickinson and Company
• Athersys, Inc.
• BioTissue
• Japan Tissue Engineering Co., Ltd.

Report Scope

This report segments the Global Tissue Engineering Market based on the following categories:

By Material Type:

• Synthetic Materials
• Biologically Derived Materials
• Others

By Application:

• Orthopedics
• Musculoskeletal & Spine
• Neurology
• Cardiology
• Skin & Integumentary
• Others

By End-User:

• Hospitals
• Cancer Research Centers
• Academic and Research Institutes
• Others

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape and Company Profiles:

The report includes detailed analyses of the major companies operating in the Global Tissue Engineering Market.

Available Customizations:

TechSci Research offers the ability to customize the report according to a company's specific needs, including profiling additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Tissue Engineering Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Material Type (Synthetic Materials, Biologically Derived Materials, Others)
  • 4.2.2. By Application (Orthopedics, Musculoskeletal & Spine, Neurology, Cardiology, Skin & Integumentary, Others)
  • 4.2.3. By End User (Hospitals, Cancer Research Centers, Academic and Research Institutes, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Material Type
  • 4.3.2. By Application
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Tissue Engineering Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material Type
  • 5.2.2. By Application
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Tissue Engineering Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Material Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By End User
  • 5.3.2. India Tissue Engineering Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Material Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Tissue Engineering Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Material Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Tissue Engineering Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Material Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Tissue Engineering Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Material Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By End User

6. Europe Tissue Engineering Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Tissue Engineering Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Tissue Engineering Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Tissue Engineering Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Tissue Engineering Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Material Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Tissue Engineering Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Material Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. North America Tissue Engineering Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Tissue Engineering Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Tissue Engineering Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Tissue Engineering Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User

8. South America Tissue Engineering Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Tissue Engineering Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Tissue Engineering Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Tissue Engineering Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. Middle East and Africa Tissue Engineering Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Tissue Engineering Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Tissue Engineering Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Tissue Engineering Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Tissue Engineering Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Zimmer Biomet Holdings Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Stryker Corporation Holdings
• 14.3. 3D BioFibR Inc.
• 14.4. Integra LifeSciences Corporation
• 14.5. CollPlant Biotechnologies Ltd.
• 14.6. AbbVie (Allergan Aesthetics)
• 14.7. Becton, Dickinson and Company
• 14.8. Athersys, Inc.
• 14.9. BioTissue
• 14.10. Japan Tissue Engineering Co., Ltd

15. Strategic Recommendations

16. About Us & Disclaimer